Skip to content

Adaptive Announces Preliminary Fourth Quarter and Full Year 2025 Results

Read More
  • Investors
  • Join Our Team
Logo for Adaptive Biotechnologies
    • About
    • clonoSEQ MRD Test
    • Clinical Portfolio & Pipeline
    • Publications
    • Clinical Diagnostics
    • clonoSEQ
    • Biopharma Solutions
    • Biopharma Services
    • About
      • Immune Medicine Platform
      • The Adaptive Immune System
      • TCR Antigen Mapping
      • Publications
      • Pharma Services
      • TCR and BCR Sequencing Services
      • TCR Sequencing Applications
      • BCR Sequencing Applications
    • Drug Discovery
      • TCR Therapeutics
      • Antibody Therapeutics
      • Target Discovery
    • Blog
      • Adaptive Earns Cornerstone Recognition for LGBTQ+ Workplace Inclusion in HRC’s 2025 Corporate Equality Index
      • Jim’s Journey: The Power of Collaboration in Blood Cancer Care
      • Pride Month at Adaptive: Celebrating Progress and Community
      • See all posts
    • Media
      • Press Releases
      • Media Resources
      • Events
      • Conferences & Events
    • Publications
      • Research Publications
      • Credentials
      • Licenses and Accreditation
    • Medical
      • Medical Affairs
      • Medical Information
      • Data & Congresses
    • About Us
      • Who We Are
      • Our Story
      • Innovation Timeline
      • Leadership
      • Corporate Social Responsibility
    • Careers
      • Career Listings
      • Connect
      • Contact
      • Investors
      • Investor Relations
      • Newsroom
  • Terms of Service
  • Privacy Policy
  • HIPAA Notice
  • Sitemap
  • Careers
  • Contact Us
Logo for Adaptive Biotechnologies
View our facebook' View our twitter' View our instagram' View our linkedin'
© Adaptive Biotechnologies. All Rights Reserved.